Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Other arteriosclerosis

Citations 231-240 of 267 total displayed.

Past content (since Apr 1999):

Articles
Continuous Probabilistic Prediction of Angiographically Significant Coronary Artery Disease Using Electron Beam Tomography
Matthew J. Budoff, George A. Diamond, Paolo Raggi, Yadon Arad, Alan D. Guerci, Tracy Q. Callister, and Daniel Berman
Circulation published April 1, 2002, doi:10.1161/01.CIR.0000014483.43921.8C [Abstract]  

Clinical Investigations and Reports
Effect of Azithromycin Treatment on Endothelial Function in Patients With Coronary Artery Disease and Evidence of Chlamydia pneumoniae Infection
Nikhil Parchure, Emmanouil G. Zouridakis, and Juan Carlos Kaski
Circulation 2002;105:1298-1303; published online before print as doi:10.1161/hc1102.105649 [Abstract] [Full text]  

Correspondence
Immunopathogenesis of Atherosclerosis Response
Johann W. Auer, Robert Berent, Thomas Weber, Bernd Eber, Sucharit Bhakdi, Tolga Attila Sagban, Hans-Anton Lehr, Christian Ihling, Ulrich Zähringer, Klaus-Dieter Hungerer, Matthias Blumrich, and Kurt Reifenberg
Circulation 2002;105:e64 [Full text]  

Articles
Suppression of Murine Cardiac Allograft Arteriopathy by Long-Term Blockade of CD40-CD154 Interactions
Catherine Y. Wang, Sean P. Mazer, Kanji Minamoto, Shin Takuma, Shunichi Homma, Michael Yellin, Leonard Chess, Ali Fard, Susan L. Kalled, Mehmet C. Oz, and David J. Pinsky
Circulation published March 11, 2002, doi:10.1161/01.CIR.0000013022.11250.30 [Abstract]  

Articles
Effect of Azithromycin Treatment on Endothelial Function in Patients With Coronary Artery Disease and Evidence of Chlamydia pneumoniae Infection
Nikhil Parchure, Emmanouil G. Zouridakis, and Juan Carlos Kaski
Circulation published February 25, 2002, doi:10.1161/hc1102.105649 [Abstract]  

Basic Science Reports
Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction
Shunji Hayashidani, Hiroyuki Tsutsui, Tetsuya Shiomi, Nobuhiro Suematsu, Shintaro Kinugawa, Tomomi Ide, Jing Wen, and Akira Takeshita
Circulation 2002;105:868-873; published online before print as doi:10.1161/hc0702.104164 [Abstract] [Full text]  

Brief Rapid Communications
Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol
Mohamad Navab, G.M. Anantharamaiah, Susan Hama, David W. Garber, Manjula Chaddha, Greg Hough, Roger Lallone, and Alan M. Fogelman
Circulation 2002;105:290-292, doi:10.1161/hc0302.103711 [Abstract] [Full text]  

Correspondence
Effect of Ramipril and Vitamin E on Atherosclerosis Response
L. Iuliano, F. Micheletta, F. Violi, L.G. Spagnoli, Eva M. Lonn, Salim Yusuf, Qilong Yi, Sandra Smith, Anne Moore-Cox, Jackie Bosch, Vladimir Dzavik, C. Ian Doris, Ward A. Riley, and Koon K. Teo
Circulation 2002;105:e5-6e [Full text]  

Correspondence
Does Reduced Vascular Stiffening Fully Explain Preserved Cardiovagal Baroreflex Function in Older Physically Active Men? Response
Michael F. O’Rourke, Wilmer W. Nichols, Brian E. Hunt, William B. Farquhar, and J. Andrew Taylor
Circulation 2002;105:e11 [Full text]  

Articles
Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction
Shunji Hayashidani, Hiroyuki Tsutsui, Tetsuya Shiomi, Nobuhiro Suematsu, Shintaro Kinugawa, Tomomi Ide, Jing Wen, and Akira Takeshita
Circulation published January 14, 2002, doi:10.1161/hc0702.104164 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

* Subspecialty Collections Home

* Show  Other arteriosclerosis
 collections from other journals.

* Related collections:
 Atherosclerosis
 Pathophysiology
 Risk Factors
 Other arteriosclerosis